Development

Can Araman is the principal scientist, biomolecule formulation, for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Moritz Beck-Broichsitter is the associate director, formulation service, for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Nelli Erwin is the head of protein stability for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Supriyadi Hafiz is the senior scientist formulation for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Adela Kasselkus is the technical communication manager for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Thomas Kipping is the head of drug carriers for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

David Luedeker is the principal scientist, solid formulation, for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Aditi Mehta is an associate director, mRNA process and delivery, for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Lena Mueller is the head of functional excipients for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Sara S. Nogueira is a scientist, RNA drug delivery, for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Tobias Rosenkranz is the head of biomolecule formulation for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Eleni Samaridou is the principal scientist formulation service for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Johanna Simon is the principal scientist formulation service for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Articles

Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.

Seven Trends Shaping the Future of Pharmaceutical Formulation Development

Sponsors should explore key considerations ahead of choosing a new outsourcing partner.

CPHI Frankfurt: Selecting the Right Outsourcing Strategy and Partner

Editor of Pharmaceutical Technology Europe

External expertise is beneficial in helping companies select the right tools at the right stages of development to ensure success.

Adopting Smart Development Strategies

There are many benefits of employing a reformulation strategy, but companies must also overcome a variety of challenges too.

Reformulating Success

Hanna Jankevics Jones, PhD, is a pharmaceutical segment marketing manager at Malvern Panalytical.

Natalia Markova is principal scientist, MicroCal, Malvern Instruments.

Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.

Shining a Light on Lipid Nanoparticle Characterization

Meg Rivers is the former senior editor for 

Podcasts

Experts from Umoja Biopharma dive into cell therapy development in this episode of the Drug Solutions Podcast, including the greatest advancements in cell therapy to date, areas for improvement, the biggest trends in cell therapy development, and retention as a pain point. 

Drug Solutions Podcast: Cell Therapy Development: Advances, Trends, and the Challenge of Retention

Moritz Perscheid is a pharmaceutical chemist at LGC.

It is argued that orthogonal quantitative methods can be used to establish primary working standards. An example details how to calculate the expanded measurement uncertainty (U) for the certified assay value by considering two orthogonal assay methods.

The Value of Primary Working  Standards in Pharmaceutical Quality Control

It is possible to overcome some of the limitations of traditional dosage forms by employing alternative drug delivery formulation strategies.

Delivering a Difference in Formulation

Industry is adapting to the increasing complexity and poor solubility and bioavailability of molecules in the pipeline.

Adapting to Solubility/Bioavailability Challenges

Sergio A. Bernal-Chávez, PhD, is research associate at Laboratorio de Investigación y Posgrado en Tecnología Farmacéutica (L-322, Campo 1), Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México.

Sergio Alcalá-Alcalá, PhD, is principal scientist at Laboratorio de Tecnología Farmacéutica, Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, México.

Doris Cerecedo, PhD, is principal scientist at Laboratorio de Hematobiología, Escuela Nacional de Medicina y Homeopatía, Sección de Estudios de Posgrado, Instituto Politécnico Nacional, Ciudad de México.

, is principal scientist at Laboratorio de Investigación y Posgrado en Tecnología Farmacéutica (L-322, Campo 1), Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México.

The purpose of this article was to demonstrate the application of a new thermogelling matrix in the healing of wounds.